Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management
Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation
Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
Subscribe To Our Newsletter & Stay Updated